2022
DOI: 10.1111/jcmm.17437
|View full text |Cite
|
Sign up to set email alerts
|

The effect of carbamazepine on bone structure and strength in control and osteogenesis imperfecta (Col1a2+/p.G610C) mice

Abstract: The inherited brittle bone disease osteogenesis imperfecta (OI) is commonly caused by mutations that compromise the biosynthesis or structure of type I collagen, the predominant organic structural component of bone. The two collagen I α-chain subunits, α1(I) and α2(I), which form the [α1(I)] 2 α2(I) collagen protein trimers are encoded by COL1A1 and COL1A2. Autosomal dominant mutations in these genes cause more than 85% of OI cases 1,2 and fall into two broad functional groups. Mutations that reduce collagen I

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
references
References 43 publications
(120 reference statements)
0
0
0
Order By: Relevance